Merck Wins Patent Dispute Over Cancer Treatment Drug
Following a bench trial, a New Jersey federal judge on Thursday validated Merck Sharp & Dohme Corp.'s patent for an anti-nausea drug used during chemotherapy, finding that its claims are not...To view the full article, register now.
Already a subscriber? Click here to view full article